Currently, seven AOMs are approved by both the Food and Drug Administration (FDA) and European Medicines Agency (EMA) -liraglutide, semaglutide, tirzepatide, orlistat, naltrexone/bupropion, setmelanotide, and metreleptin- while two additional agents (phentermine and phentermine/topiramate) are FDA-approved only
And yet, Ive opted outnot because I feel sanctimonious about pursuing my weight-loss goals without medication (which I am), or because I think taking GLP-1s is somehow cheating or taking the easy way out (I dont, and its not), but because even though doctors have suggested I try the drugs, Im concerned about certain effects of a treatment thats only become mainstream for weight loss fairly recently
doi: 10.1097/MCC.0000000000000510 238 MotkowskiRMaciejczykMHryniewickaMKarpiskaJMikouB
However, every person is different
Carnazza M, Werner R, Begley M, Yang N, Tiwari RK, Geliebter J, et al
Documentation quality Use of batch-level documentation and traceability versus generic or reused Certificates of Analysis (COAs)